Lara Dani
Overview
Explore the profile of Lara Dani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kourie M, Bogdanovic D, Mahmutyazicioglu K, Ghazi S, Panic N, Fjellgren E, et al.
J Clin Med
. 2023 Oct;
12(19).
PMID: 37834983
Introduction: Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition associated with fibroinflammatory lesions that can occur at almost any anatomical site. It often presents as a multiorgan disease that may...
2.
Argyriou A, Horuluoglu B, Galindo-Feria A, Diaz-Boada J, Sijbranda M, Notarnicola A, et al.
EMBO Mol Med
. 2023 Jul;
15(10):e17240.
PMID: 37522383
Idiopathic inflammatory myopathies (IIM) are rare autoimmune systemic diseases characterized by muscle weakness and the presence of muscle-infiltrating T cells. IIM represent a clinical challenge due to heterogeneity of symptoms...
3.
Cordel N, Dechelotte B, Jouen F, Lamb J, Chinoy H, New P, et al.
Rheumatology (Oxford)
. 2022 Oct;
62(4):1711-1715.
PMID: 36250907
Objective: To assess the role of the anti-TIF1γ auto-antibody (aAb) IgG2 isotype as a biomarker of cancer in anti-TIF1γ aAb-positive adult DM. Methods: International multicentre retrospective study with the following...
4.
Lodin K, Notarnicola A, Dastmalchi M, Dani L, Svensson A, Ronnelid J, et al.
Lakartidningen
. 2022 Sep;
119.
PMID: 36082925
Interstitial lung disease can be the first sign of systemic autoimmune disease. If associated with myositis, interstitial lung disease may be the only symptom, with no presence of muscular weakness...
5.
Selickaja S, Galindo-Feria A, Dani L, Mimori T, Ronnelid J, Holmqvist M, et al.
Rheumatology (Oxford)
. 2022 May;
61(12):4991-4996.
PMID: 35579337
Objectives: Anti-TIF1-gamma autoantibodies can be detected with immunoprecipitation (IP), line blot (LB) and ELISA. We compared assay performance in patients with DM and the potential of these assays to detect...
6.
Nikolic S, Panic N, Hintikka E, Dani L, Rutkowski W, Hedstrom A, et al.
Scand J Gastroenterol
. 2021 Aug;
56(11):1355-1362.
PMID: 34410885
Introduction: Autoimmune pancreatitis (AIP) is a special form of pancreatitis that responds well to glucocorticoid (GC) treatment. Relapses of AIP are common. The anti-CD20 antibody rituximab (RTX) has shown promising...
7.
Dani L, Che W, Lundberg I, Hellgren K, Holmqvist M
Semin Arthritis Rheum
. 2021 Jan;
51(1):331-337.
PMID: 33508731
Objective: To examine the association between idiopathic inflammatory myopathy (IIM) and cancer before and after IIM diagnosis. Methods: We used prospectively collected nationwide register data to design a case-control study...
8.
Barsotti S, Dastmalchi M, Notarnicola A, Leclaire V, Dani L, Gheorghe K, et al.
Semin Arthritis Rheum
. 2020 Feb;
50(3):492-497.
PMID: 32024593
Background: In 2017, the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) published new classification criteria for idiopathic inflammatory myopathies (IIM). Objectives: To [1] assess the...
9.
Dani L, Holmqvist M, Martinez M, Trallero-Araguas E, Dastmalchi M, Svensson J, et al.
Clin Exp Rheumatol
. 2019 Aug;
38(1):67-73.
PMID: 31365334
Objectives: To investigate anti-TIF1-γ antibodies in longitudinally followed patients with myositis and cancer. Methods: Serum levels of anti-TIF1-γ antibodies at different time-points in relation to myositis and cancer diagnosis were...
10.
Parodis I, Dani L, Notarnicola A, Martenhed G, Fernstrom P, Matikas A, et al.
Autoimmun Rev
. 2019 Apr;
18(6):615-620.
PMID: 30959218
Background: Febrile neutropenia is generally recognised as a complication of myelosuppressive chemotherapy. Recombinant human granulocyte colony stimulating factor (G-CSF) is commonly used as a primary or secondary prophylaxis to reduce...